We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Returns Tysabri to Market Despite Continued Risks of Fatality
FDA Returns Tysabri to Market Despite Continued Risks of Fatality
June 5, 2006
The FDA has made the “rare” decision to allow a drug to be sold after the product was pulled from the market due to serious health concerns, despite the agency’s acknowledgement that there will continue to be deaths related to the drug’s use, an official said.